# Joanna Tyrekidis

> Joanna Tyrekidis is a Series B investor at Meusinvest (Noshaq) backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest)
- Total investments: 1
- Last investment: Jun 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/joanna-tyrekidis-78733415/

Joanna Tyrekidis is a Series B investor at Meusinvest (Noshaq) focused on Medical and Health Care. Joanna Tyrekidis is the CEO of Noshaq Spin-Offs. He attended HEC Liège.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CryoTherapeutics | CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries. | $7.7M | Series B | Jun 27, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Creathor Ventures](https://shizune.co/investors/profile/creathor-venture-management) — VC Fund, 1 deal together
- [Peppermint Venture Partners](https://shizune.co/investors/profile/peppermint-venture-partners) — VC Fund, 1 deal together

## About Meusinvest (Noshaq)

VC Fund · Liège, Belgium

Noshaq offers financial services to help businesses develop.

3 contacts available at Meusinvest (Noshaq).

| Name | Title | Profile |
| --- | --- | --- |
| Alain Balthazart | Investment Manager | https://shizune.co/investors/profile/alain-balthazart |
| Gérôme Vanherf | Program Manager | https://shizune.co/investors/profile/g%C3%A9r%C3%B4me-vanherf |
| Joanna Tyrekidis | CEO of Noshaq Spin-Offs; Investment Manager | https://shizune.co/investors/profile/joanna-tyrekidis |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Joanna Tyrekidis invest in?

Joanna Tyrekidis invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Joanna Tyrekidis last invest?

The most recent investment recorded for Joanna Tyrekidis closed in Jun 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co